Home

Pfizer (PFE)

23.46
-0.03 (-0.13%)
NYSE · Last Trade: Jun 3rd, 3:50 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
3 Safe Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 11.35% -- That Make for No-Brainer Buys in Junefool.com
Three supercharged dividend stocks have the tools and intangibles to fatten investors' pocketbooks in June, and well beyond.
Via The Motley Fool · June 3, 2025
Why BioNTech Stock Soared Todayfool.com
Bristol Myers Squibb just agreed to shower BioNTech with cash.
Via The Motley Fool · June 2, 2025
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Pfizer (NYSE:PFE)
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Pfizer (NYSE:PFE) and its peers.
Via StockStory · June 1, 2025
Terrible News for Pfizer Stock Investorsfool.com
Via The Motley Fool · June 1, 2025
Beat the S&P 500 With This Cash-Gushing Dividend Stockfool.com
The business may be somewhat boring, but it consistently delivers year after year, resulting in tremendous long-term returns.
Via The Motley Fool · June 1, 2025
Pfizer's Mega Deal Highlights China's Rising Role In Global Pharmabenzinga.com
Via Benzinga · May 29, 2025
P/E Ratio Insights for Pfizerbenzinga.com
Via Benzinga · May 20, 2025
Pfizer Reports Survival Gains In Colorectal Cancer Study, Combo Therapy Cuts Death Risk By Over 50%benzinga.com
Pfizer's BRAFTOVI combo cut death risk by 51% and more than doubled survival in BRAF-mutant colorectal cancer in a Phase 3 trial.
Via Benzinga · May 30, 2025
2 Large-Cap Stocks to Target This Week and 1 to Keep Off Your Radar
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
Via StockStory · May 30, 2025
Robert F. Kennedy Jr. Says CDC Drops COVID Vaccine For 'Healthy' Pregnant Women, Childrenbenzinga.com
RFK Jr. says the COVID-19 vaccine is no longer on the CDC's recommended schedule for healthy kids and pregnant women, though the official site still shows it listed.
Via Benzinga · May 27, 2025
Is Pfizer Stock a Buy After This $1.25 Billion Investment?fool.com
Via The Motley Fool · May 27, 2025
Down 63%, Should You Buy the Dip on Pfizer?fool.com
Pfizer has taken its lumps lately. It's time to wonder whether the stock can make a comeback.
Via The Motley Fool · May 24, 2025
1 Ultra-High-Yield Dividend Stock Down 57% to Buy Hand Over Fistfool.com
Via The Motley Fool · May 24, 2025
U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Resultfool.com
There's little doubt these pharmaceutical companies' costs will soon be rising at least a little.
Via The Motley Fool · May 24, 2025
Pfizer's 7.5% Dividend: Income Haven or House of Cards?
Pfizer's high dividend yield warrants scrutiny regarding its sustainability, given changing revenues and pipeline investments.
Via MarketBeat · May 23, 2025
Pfizer Stock Analysis: Buy, Sell, or Hold?fool.com
Via The Motley Fool · May 23, 2025
3 Stocks Under $10 Skating on Thin Ice
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be careful as many have risky business models.
Via StockStory · May 23, 2025
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yieldsbenzinga.com
Via Benzinga · May 22, 2025
2 High-Yield Dividend Stocks to Buy Right Nowfool.com
Via The Motley Fool · May 21, 2025
FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr.benzinga.com
The U.S. Food and Drug Administration has announced significant changes to COVID-19 vaccine requirements, limiting annual booster approvals to older and high-risk Americans while implementing stricter clinical trial requirements for healthy adults.
Via Benzinga · May 21, 2025
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030fool.com
Via The Motley Fool · May 21, 2025
Stay informed about the most active stocks in the S&P500 index on Tuesday's session.chartmill.com
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.
Via Chartmill · May 20, 2025
Pfizer Stock Is Trading Higher Tuesday: What's Going On?benzinga.com
Pfizer Inc (NYSE:PFE) shares are moving higher Tuesday following multiple developments. Here's a look at what's going on.
Via Benzinga · May 20, 2025
FDA Sets New Guidelines For Approving COVID-19 Booster Shots In Healthy Individuals: Moderna, Novavax Stocks Risestocktwits.com
The agency plans to demand stronger evidence of efficacy for the shots before approval is granted for healthy persons, between the ages of six months and 64 years, with no risk factors for severe COVID-19 infection.
Via Stocktwits · May 20, 2025
The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped.investors.com
The new framework limits future Covid shots to people age 65 and older and those six months and older with a risk factor for serious illness.
Via Investor's Business Daily · May 20, 2025